Osage backs Otonomy

Sep 5, 2013 •

Biopharma company Otonomy receives $49.5m series C from numerous backers, including university investment consortium Osage University Partners.

Otonomy, a US-based pharmaceutical company, has raised $49.5m in a series C round backed by university investment consortium Osage University Partners.
The round was led by OrbiMed Advisors, with Aperture Venture Partners and Osage as new investors. Existing investors Avalon Ventures, Domain Associates, Novo Ventures, RiverVest Venture Partners and TPG Biotech also participated.
Otonomy, founded in 2008, focuses on developing innovative therapeutics for ear-based diseases and disorders, with two products, OTO-104 and OTO-201, currently in clinical trials. The…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?

LEADERSHIP SOCIETY

Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.

Find out more

Podcast: South Africa is building a world-class innovation ecosystem

In 2020, Stellenbosch University launched Africa's first-ever university venture fund focused on spinouts — here's how it's reshaping the country.

Singapore medical school launches $15m incubator to create spinouts

Live Ventures will fund spinouts and mentor academic researchers from the medical university.

Cardiff University sets out to be leader in social sciences spinouts

The UK university sees its focus on social sciences spinouts as a way to drive civic engagement.

Events

Webinar: Collaborating with startups - CVC 'platforms' or 'venture client' programs?

Aug 14, 2024
Online

Find out more All events

Events

GCV Connect: New Nordics 2024

Sep 16 -
Sep 17, 2024
Helsinki (Finland) & Tallinn (Estonia)

Find out more All events

Events

GCV Institute: CVC Investment Programs

Sep 24 -
Sep 25, 2024
Online

Find out more All events

Events

GCV Institute: Landing the Value of Corporate Venturing

Oct 18 -
Oct 21, 2024
Online

Find out more All events

Events

GCV Executive Leadership Forum 2024

Oct 24, 2024
Menlo Park, CA (USA)

Find out more All events

Events

Corporate Venture in Brasil 2024 – International Delegation to Brazil

Oct 28 -
Oct 30, 2024
São Paulo (Brazil)

Find out more All events

Events

GCV Connect: Germany 2024

Oct 29, 2024
Frankfurt (Germany)

Find out more All events

Events

GCV Asia Congress & International Delegation 2024

Nov 11 -
Nov 14, 2024
Tokyo (Japan)

Find out more All events

Events

GCVI Summit 2025

Mar 18 -
Mar 20, 2025
Monterey, CA (USA)

Find out more All events

About us

Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.